| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $680K | +57.6% |
| SG&A Expense | $1.2M | -16.7% |
| Interest Expense | $3K | — |
| Net Income | -$2.2M | -4.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5K | +122.9% |
| Current Assets | $5K | -91.9% |
| Total Assets | $5K | -91.9% |
| Total Liabilities | $470K | +232.1% |
| Stockholders' Equity | -$465K | -478.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +18.0% |
| Financing Cash Flow | $1.2M | -14.6% |